MIDDLE EAST PHARMACEUTICAL INDUSTRIES TADAWUL:4016:
FY NET PROFIT 97.01 MILLION RIYALS
FY SALES 460.48 MILLION RIYALS
Avalon Pharma FY Profit 97.01 Mln Riyals
Earlier from Middle East Pharmaceutical Industries
- Avalon Pharma Contract Sign Off With Bio-Thera Solutions
- Avalon Pharma Grants Three Bonus Shares For Every Four Shares Held
- Avalon Pharma Signs Non-Binding Memorandum Of Understanding With Benta Sas
- Avalon Pharma Q3 Profit SAR 8.28 Mln